113 related articles for article (PubMed ID: 8840151)
1. Protective effect of recombinant interferon (IFN)-alpha/beta on MHV-2cc-induced chronic hepatitis in athymic nude mice.
Uetsuka K; Nakayama H; Goto N
Exp Anim; 1996 Jul; 45(3):293-7. PubMed ID: 8840151
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of a novel quinone derivative, E3330, on mouse hepatitis virus (MHV)-induced chronic hepatitis in athymic nude mice.
Uetsuka K; Suzuki M; Kai C; Goto N
Exp Anim; 1997 Jul; 46(3):219-23. PubMed ID: 9250483
[TBL] [Abstract][Full Text] [Related]
3. Synergistic antiviral effect of a combination of mouse interferon-alpha and interferon-gamma on mouse hepatitis virus.
Fuchizaki U; Kaneko S; Nakamoto Y; Sugiyama Y; Imagawa K; Kikuchi M; Kobayashi K
J Med Virol; 2003 Feb; 69(2):188-94. PubMed ID: 12683406
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the alpha/beta interferon response by mouse hepatitis virus at multiple levels.
Roth-Cross JK; Martínez-Sobrido L; Scott EP; García-Sastre A; Weiss SR
J Virol; 2007 Jul; 81(13):7189-99. PubMed ID: 17459917
[TBL] [Abstract][Full Text] [Related]
5. Hepatitogenicity of three plaque purified variants of hepatotropic mouse hepatitis virus, MHV-2 in athymic nude mice.
Uetsuka K; Nakayama H; Goto N
Exp Anim; 1996 Apr; 45(2):183-7. PubMed ID: 8726145
[TBL] [Abstract][Full Text] [Related]
6. Expression of CXC chemokine ligand 10 from the mouse hepatitis virus genome results in protection from viral-induced neurological and liver disease.
Walsh KB; Edwards RA; Romero KM; Kotlajich MV; Stohlman SA; Lane TE
J Immunol; 2007 Jul; 179(2):1155-65. PubMed ID: 17617609
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of recombinant murine interferon beta against mouse hepatitis virus infection.
Minagawa H; Takenaka A; Mohri S; Mori R
Antiviral Res; 1987 Sep; 8(2):85-95. PubMed ID: 2830846
[TBL] [Abstract][Full Text] [Related]
8. Insertion of the CXC chemokine ligand 9 (CXCL9) into the mouse hepatitis virus genome results in protection from viral-induced encephalitis and hepatitis.
Muse M; Kane JA; Carr DJ; Farber JM; Lane TE
Virology; 2008 Dec; 382(2):132-44. PubMed ID: 18973912
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of mouse hepatitis virus infection in gamma interferon-deficient mice is modulated by co-infection with Helicobacter hepaticus.
Compton SR; Ball-Goodrich LJ; Zeiss CJ; Johnson LK; Johnson EA; Macy JD
Comp Med; 2003 Apr; 53(2):197-206. PubMed ID: 12784855
[TBL] [Abstract][Full Text] [Related]
10. Differences between BALB/c and C57BL/6 mice in mouse hepatitis virus replication in primary hepatocyte culture.
Kyuwa S; Kawamura S; Tagawa Y; Iwakura Y; Urano T; Yoshikawa Y
Exp Anim; 2003 Jan; 52(1):81-4. PubMed ID: 12638242
[TBL] [Abstract][Full Text] [Related]
11. Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis.
Navas S; Seo SH; Chua MM; Das Sarma J; Lavi E; Hingley ST; Weiss SR
J Virol; 2001 Mar; 75(5):2452-7. PubMed ID: 11160748
[TBL] [Abstract][Full Text] [Related]
12. Tissue distribution and duration of mouse hepatitis virus in naturally infected immunocompetent ICR (CD-1) and immunodeficient athymic nude-nu mouse strains used for ovarian transplantation and in vitro fertilization.
Scavizzi F; Raspa M
Lab Anim; 2004 Apr; 38(2):189-99. PubMed ID: 15070459
[TBL] [Abstract][Full Text] [Related]
13. The protective role of cytotoxic T cells and interferon against coronavirus invasion of the brain.
Lavi E; Wang Q
Adv Exp Med Biol; 1995; 380():145-9. PubMed ID: 8830471
[TBL] [Abstract][Full Text] [Related]
14. Enterotropic coronavirus (mouse hepatitis virus) in mice: influence of host age and strain on infection and disease.
Barthold SW; Beck DS; Smith AL
Lab Anim Sci; 1993 Aug; 43(4):276-84. PubMed ID: 8231082
[TBL] [Abstract][Full Text] [Related]
15. Ifit2 deficiency results in uncontrolled neurotropic coronavirus replication and enhanced encephalitis via impaired alpha/beta interferon induction in macrophages.
Butchi NB; Hinton DR; Stohlman SA; Kapil P; Fensterl V; Sen GC; Bergmann CC
J Virol; 2014 Jan; 88(2):1051-64. PubMed ID: 24198415
[TBL] [Abstract][Full Text] [Related]
16. Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection.
Cervantes-Barragán L; Kalinke U; Züst R; König M; Reizis B; López-Macías C; Thiel V; Ludewig B
J Immunol; 2009 Jan; 182(2):1099-106. PubMed ID: 19124753
[TBL] [Abstract][Full Text] [Related]
17. Intranasally administered alpha/beta interferon prevents extension of mouse hepatitis virus, strain JHM, into the brains of BALB/cByJ mice.
Smith AL; Barthold SW; Beck DS
Antiviral Res; 1987 Dec; 8(5-6):239-45. PubMed ID: 2837142
[TBL] [Abstract][Full Text] [Related]
18. γδ T Cells Contribute to the Outcome of Murine Fulminant Viral Hepatitis via Effector Cytokines TNF-α and IFN-γ.
Wu D; Yan WM; Wang HW; Huang D; Luo XP; Ning Q
Curr Med Sci; 2018 Aug; 38(4):648-655. PubMed ID: 30128874
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of murine recombinant interferon-beta administered by intravenous, intramuscular or subcutaneous route on mouse hepatitis virus infection.
Matsuyama S; Henmi S; Ichihara N; Sone S; Kikuchi T; Ariga T; Taguchi F
Antiviral Res; 2000 Aug; 47(2):131-7. PubMed ID: 10996401
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and alpha interferon for interferon regulatory factor 1.
Kawamoto S; Oritani K; Asada H; Takahashi I; Ishikawa J; Yoshida H; Yamada M; Ishida N; Ujiie H; Masaie H; Tomiyama Y; Matsuzawa Y
J Virol; 2003 Sep; 77(17):9622-31. PubMed ID: 12915574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
